Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade

Core Viewpoint - Passage Bio, Inc. (PASG) has seen a significant stock price increase of 31.5% over the past four weeks, closing at $7.59, with analysts suggesting a potential upside of 1415.2% based on a mean price target of $115 [1][2]. Price Targets and Analyst Estimates - The mean estimate of $115 is derived from four short-term price targets, with the lowest estimate at $40.00 indicating a 427% increase, while the highest target suggests a surge of 3325.6% to $260.00 [2]. - The standard deviation of $103.76 indicates variability among analysts' estimates, with a smaller standard deviation suggesting greater agreement [2][9]. Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising earnings estimates higher for PASG, which is a positive indicator for potential stock upside [4][11]. - The Zacks Consensus Estimate for the current year has increased by 8.7% over the past month, with no negative revisions, further supporting the optimistic outlook [12]. Zacks Rank and Investment Potential - PASG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13]. - While consensus price targets may not be entirely reliable, the direction they imply appears to be a useful guide for potential price movement [14].